Stable Targeted Integration of Exogenous Sequences
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional cell line engineering methods for recombinant therapeutic protein expression result in unstable and heterogeneous cell lines due to random integration of transgenes, lacking predictable and stable expression.
Innovation Solution
The method involves integrating exogenous sequences into specific genomic loci using targeting endonucleases like ZFNs or CRISPR/Cas systems at predetermined sites within the genome, ensuring stable and predictable expression without affecting cellular function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If random integration of transgenes is used, then cell lines can be developed for recombinant therapeutic protein expression, but the cell lines become unstable and heterogeneous in expression
Solution Approach 1:
The patent segments the genome into specific functional regions (safe harbors) that can accept transgene integration without disrupting essential cellular functions. By identifying and utilizing specific genomic loci such as those containing housekeeping genes or non-coding regions, the method enables targeted insertion of therapeutic protein cassettes at predetermined locations, thereby achieving both high productivity and stable, homogeneous expression across cell lines.
Solution Approach 2:
The patent employs targeting endonucleases (such as ZFNs, TALENs, or CRISPR-Cas systems) as intermediary tools to mediate site-specific integration of transgenes. These enzymes create controlled double-strand breaks at specific genomic locations, facilitating precise insertion of therapeutic cassettes into safe harbor regions. This intermediary mechanism enables deterministic integration rather than random insertion, resolving the contradiction between productivity and stability.
2Stability of the object's composition
If site-specific targeted integration is used, then stable and predictable transgene expression is achieved, but suitable genomic locations must be identified and verified
Solution Approach 1:
The patent performs preliminary identification and characterization of safe harbor genomic loci before actual transgene integration. By pre-mapping suitable integration sites that meet specific criteria (such as being within introns of housekeeping genes or in non-coding regions), the method establishes a library of validated target locations. This preliminary action simplifies subsequent integration experiments and ensures stable expression without requiring de novo verification for each new transgene.
Solution Approach 2:
The patent utilizes the cell's own genomic architecture and natural DNA repair mechanisms to facilitate site-specific integration. By designing transgene cassettes with homology arms that match the target safe harbor region, the method leverages homology-directed repair (HDR) pathways to achieve precise integration. This self-service approach reduces the need for complex external intervention and simplifies the overall integration process.
Data Source
AI summary
Methods for integrating exogenous sequences in genomic loci, wherein the integration is stable and the exogenous sequence can function predictably and reliably.